PD-1

You have access
Highly Activated PD-1/PD-L1 Pathway in Gastric Cancer with PD-L1 Expression
HIROAKI SAITO, YUSUKE KONO, YUKI MURAKAMI, YUJI SHISHIDO, HIROHIKO KURODA, TOMOYUKI MATSUNAGA, YOJI FUKUMOTO, TOMOHIRO OSAKI, KEIGO ASHIDA and YOSHIYUKI FUJIWARA

Anticancer Research January 2018, 38 (1) 107-112;
You have access
Comparison of PD-L1 mRNA Expression Measured with the CheckPoint Typer® Assay with PD-L1 Protein Expression Assessed with Immunohistochemistry in Non-small Cell Lung Cancer
RAMONA ERBER, ROBERT STÖHR, STEFANIE HERLEIN, CLAUDIA GIEDL, RALF JOACHIM RIEKER, FLORIAN FUCHS, JOACHIM H. FICKER, ARNDT HARTMANN, ELKE VELTRUP, RALPH M. WIRTZ and WOLFGANG M. BRUECKL

Anticancer Research December 2017, 37 (12) 6771-6778;
You have access
Immune Checkpoint Inhibitors in Gynecological Cancers: Update of Literature and Perspectives of Clinical Research
ANGIOLO GADDUCCI and MARIA ELENA GUERRIERI

Anticancer Research November 2017, 37 (11) 5955-5965;
You have access
Gastrocutaneous Fistula in a Patient with Locally Recurrent MSI-High Colorectal Cancer: Local Complications Arising from Therapeutic Response to Immune Checkpoint Blockade
CLAIRE GREENE, ERIC K. NAKAKURA and ANDREW H. KO

Anticancer Research July 2017, 37 (7) 3679-3684;
You have access
Immune Blockade Inhibition in Breast Cancer
IOANNIS A. VOUTSADAKIS

Anticancer Research November 2016, 36 (11) 5607-5622;
You have access
Combination Immunotherapy with 4-1BB Activation and PD-1 Blockade Enhances Antitumor Efficacy in a Mouse Model of Subcutaneous Tumor
YOSHITARO SHINDO, KIYOSHI YOSHIMURA, ATSUO KURAMASU, YUSAKU WATANABE, HIDEAKI ITO, TOMOKO KONDO, ATSUNORI OGA, HIROSHI ITO, SHIGEFUMI YOSHINO, SHOICHI HAZAMA, KOJI TAMADA, HIDEO YAGITA and MASAAKI OKA

Anticancer Research January 2015, 35 (1) 129-136;

Main menu

User menu

Search

PD-1

Pages